Willkommen
Über uns
Investoren
Drittmittelgeber
GILUPI-Technologie
Forschung & Entwicklung
Kooperationen
Karriere
News
Archiv
Veranstaltungen
Veröffentlichungen
Downloads
Kontakt
Anfahrt
Impressum
Willkommen
Über uns
Investoren
Drittmittelgeber
GILUPI-Technologie
Forschung & Entwicklung
Kooperationen
Karriere
News
Archiv
Veranstaltungen
Veröffentlichungen
Downloads
Kontakt
Anfahrt
Impressum
Drittmittelgeber
Bundesministerium
für Bildung und Forschung
Bundesministerium
für Wirtschaft und Technologie
Zukunftsagentur Brandenburg
InvestitionsBank
des Landes Brandenburg
Life Science News (
bionity.com
)
Q-Biologicals signs a service framework agreement with Bayer CropScience
Q-Biologicals, a biotech company focused on providing services in the field of process development and manufacturing of recombinant proteins, viruses and live cells, announced that it has entered into a service framework agreement with Bayer CropScience to produce and purify recombinant proteins for...
VTT searches for novel biomarkers and targets for preventing or treating type 2 diabetes
VTT is participating in two new European projects focusing on type 2 diabetes. The projects aim at identifying new therapeutic choices and strategies for preventing the disease. Focus is on obtaining information on cellular dysfunction in diabetes and the effects of changes in lifestyle. The goal i...
Abbott Receives Positive Opinion for HUMIRA in Ulcerative Colitis from EMA's CHMP
Abbott announced that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for HUMIRA® (adalimumab) in adults with moderate to severely active ulcerative colitis (UC) who have not responded to, cannot tolerate or have medical contraindications to conventio...
